(Q49160789)

18 February 2018

title

Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. (English)

1 reference

18 February 2018

1 reference

3

1 reference

18 February 2018

author name string

Adám Dénes

1

1 reference

18 February 2018

Szilamér Ferenczi

2

1 reference

18 February 2018

Zsuzsanna Környei

4

1 reference

18 February 2018

Krisztina J Kovács

5

1 reference

18 February 2018

publication date

25 June 2008

1 reference

18 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

18 February 2018

volume

28

1 reference

18 February 2018

issue

10

1 reference

18 February 2018

page(s)

1707-1721

1 reference

18 February 2018

Neuronal 'On' and 'Off' signals control microglia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Control of microglial neurotoxicity by the fractalkine receptor

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Proliferating resident microglia after focal cerebral ischaemia in mice.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Blood monocytes consist of two principal subsets with distinct migratory properties

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

A novel role of interleukin-1-converting enzyme in cytokine-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Production of monocyte chemoattractant protein-1 and cytokine-induced neutrophil chemoattractant-1 in rat brain is stimulated by intracerebroventricular administration of an endothelin ETB receptor agonist

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: Apomorphine-induced reversal of deficits

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Systemic inflammation and stroke: aetiology, pathology and targets for therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Inflammation and ischaemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Induction of heme oxygenase-1 after hyperosmotic opening of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Potential mechanisms of interleukin-1 involvement in cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

No role for interleukin-18 in acute murine stroke-induced brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Post-ischemic inflammation: molecular mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.64

7 January 2021

Identifiers

DOI

10.1038/JCBFM.2008.64

1 reference

18 February 2018

1 reference

18 February 2018